Advertisement
Screener

Perrigo Company plc (PRGO) Payments for Restructuring

2.8 / 5 stars · 68/120 Roast Me

Perrigo Company plc Payments for Restructuring

Perrigo Company plc (PRGO) reported Payments for Restructuring of $34.80 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsForRestructuring · last filed 2026-08-05

  • Perrigo Company plc payments for restructuring for the quarter ending 2026-06-27 was $34.80M, a 241.18% increase year-over-year.
  • Perrigo Company plc payments for restructuring for the quarter ending 2026-03-28 was $15.30M, a 7.83% decline year-over-year.
  • Perrigo Company plc payments for restructuring for the quarter ending 2025-12-31 was $17.60M, a 27.27% decline year-over-year.
  • Perrigo Company plc payments for restructuring for the quarter ending 2025-09-27 was $10.80M, a 33.74% decline year-over-year.
  • Perrigo Company plc payments for restructuring for fiscal 2025 was $60.80M, a 22.84% decline from fiscal 2024.
  • Perrigo Company plc payments for restructuring for fiscal 2024 was $78.80M, a 135.93% increase from fiscal 2023.
  • Perrigo Company plc payments for restructuring for fiscal 2023 was $33.40M, a 12.08% increase from fiscal 2022.
  • Perrigo Company plc payments for restructuring for fiscal 2022 was $29.80M, a 56.84% increase from fiscal 2021.
Period endPayments for Restructuring 3 monthPayments for Restructuring 6 monthPayments for Restructuring 9 monthPayments for Restructuring 9 month as first filedPayments for Restructuring 12 monthPayments for Restructuring 12 month as first filed
2026-06-27$34.80M
10-Q · filed 2026-08-05
$50.10M
10-Q · filed 2026-08-05
$67.70M
derived: sum of 3 quarters · filed 2026-08-05
$78.50M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$15.30M
10-Q · filed 2026-05-06
$32.90M
derived: sum of 2 quarters · filed 2026-05-06
$43.70M
derived: sum of 3 quarters · filed 2026-05-06
$53.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$17.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$28.40M
derived: sum of 2 quarters · filed 2026-02-26
$38.60M
derived: sum of 3 quarters · filed 2026-08-05
$60.80M
10-K · filed 2026-02-26
2025-09-27$10.80M
10-Q · filed 2025-11-05
$21.00M
derived: sum of 2 quarters · filed 2026-08-05
$43.20M
10-Q · filed 2025-11-05
$61.80M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28$10.20M
10-Q · filed 2026-08-05
$32.50M
10-Q · filed 2026-08-05
$51.00M
derived: sum of 3 quarters · filed 2026-08-05
$67.30M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$16.60M
10-Q · filed 2026-05-06
$40.80M
derived: sum of 2 quarters · filed 2026-05-06
$57.10M
derived: sum of 3 quarters · filed 2026-05-06
$84.80M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$24.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$40.50M
derived: sum of 2 quarters · filed 2026-02-26
$68.20M
derived: sum of 3 quarters · filed 2026-02-26
$78.80M
10-K · filed 2026-02-26
2024-09-28$16.30M
10-Q · filed 2025-11-05
$44.00M
derived: sum of 2 quarters · filed 2025-11-05
$54.60M
10-Q · filed 2025-11-05
$61.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-29$27.70M
10-Q · filed 2025-08-06
$38.30M
10-Q · filed 2025-08-06
$45.50M
derived: sum of 3 quarters · filed 2026-02-26
$54.50M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-30$10.70M
10-Q · filed 2025-05-07
$17.80M
derived: sum of 2 quarters · filed 2026-02-26
$26.80M
derived: sum of 3 quarters · filed 2026-02-26
$36.10M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.10M
derived: sum of 2 quarters · filed 2026-02-26
$25.40M
derived: sum of 3 quarters · filed 2026-02-26
$33.40M
10-K · filed 2026-02-26
2023-09-30$9.00M
10-Q · filed 2024-11-06
$18.30M
derived: sum of 2 quarters · filed 2024-11-06
$26.30M
10-Q · filed 2024-11-06
$37.10M
derived: sum of 4 quarters · filed 2025-02-28
2023-07-01$9.30M
10-Q · filed 2024-08-02
$17.30M
10-Q · filed 2024-08-02
$28.10M
derived: sum of 3 quarters · filed 2025-02-28
$41.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-04-01$8.00M
10-Q · filed 2024-05-07
$18.80M
derived: sum of 2 quarters · filed 2025-02-28
$31.70M
derived: sum of 3 quarters · filed 2025-02-28
$35.60M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$10.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$23.70M
derived: sum of 2 quarters · filed 2025-02-28
$27.60M
derived: sum of 3 quarters · filed 2025-02-28
$29.80M
10-K · filed 2025-02-28
2022-10-01$12.90M
10-Q · filed 2023-11-07
$16.80M
derived: sum of 2 quarters · filed 2023-11-07
$19.00M
10-Q · filed 2023-11-07
$24.60M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02$3.90M
10-Q · filed 2023-08-08
$6.00M
10-Q · filed 2023-08-08
$11.70M
derived: sum of 3 quarters · filed 2024-02-27
$15.40M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02$2.10M
10-Q · filed 2023-05-09
$7.80M
derived: sum of 2 quarters · filed 2024-02-27
$11.50M
derived: sum of 3 quarters · filed 2024-02-27
$16.60M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$9.40M
derived: sum of 2 quarters · filed 2024-02-27
$14.50M
derived: sum of 3 quarters · filed 2024-02-27
$19.00M
10-K · filed 2024-02-27
2021-10-02$3.70M
10-Q · filed 2022-11-08
$8.80M
derived: sum of 2 quarters · filed 2022-11-08
$13.30M
10-Q · filed 2022-11-08
$13.70M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03$5.10M
10-Q · filed 2022-08-09
$9.50M
10-Q · filed 2022-08-09
$10.00M
derived: sum of 3 quarters · filed 2023-02-28
$12.90M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03$4.40M
10-Q · filed 2022-05-11
$4.90M
derived: sum of 2 quarters · filed 2023-02-28
$7.80M
derived: sum of 3 quarters · filed 2023-02-28
$15.10M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$3.40M
derived: sum of 2 quarters · filed 2023-02-28
$10.70M
derived: sum of 3 quarters · filed 2023-02-28
$14.20M
10-K · filed 2023-02-28
$14.30M
10-K · filed 2021-03-01
2020-09-26$2.90M
10-Q · filed 2021-11-12
$10.20M
derived: sum of 2 quarters · filed 2021-11-12
$13.70M
10-Q · filed 2021-11-12
$13.80M
10-Q · filed 2020-11-05
$17.60M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27$7.30M
10-Q · filed 2021-08-11
$10.80M
10-Q · filed 2021-08-11
$14.70M
derived: sum of 3 quarters · filed 2022-03-01
$21.70M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$3.50M
10-Q · filed 2021-05-12
$7.40M
derived: sum of 2 quarters · filed 2022-03-01
$14.40M
derived: sum of 3 quarters · filed 2022-03-01
$23.40M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$3.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$10.90M
derived: sum of 2 quarters · filed 2022-03-01
$19.90M
derived: sum of 3 quarters · filed 2022-03-01
$28.90M
10-K · filed 2022-03-01
$29.40M
10-K · filed 2020-02-27
2019-09-28$7.00M
10-Q · filed 2020-11-05
$16.00M
derived: sum of 2 quarters · filed 2020-11-05
$25.00M
10-Q · filed 2020-11-05
$28.40M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29$9.00M
10-Q · filed 2020-08-05
$18.00M
10-Q · filed 2020-08-05
$21.40M
derived: sum of 3 quarters · filed 2021-03-01
$23.10M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30$9.00M
10-Q · filed 2020-05-05
$12.40M
derived: sum of 2 quarters · filed 2021-03-01
$14.10M
derived: sum of 3 quarters · filed 2021-03-01
$17.20M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$5.10M
derived: sum of 2 quarters · filed 2021-03-01
$8.20M
derived: sum of 3 quarters · filed 2021-03-01
$18.80M
10-K · filed 2021-03-01
2018-09-29$1.70M
10-Q · filed 2019-11-06
$4.80M
derived: sum of 2 quarters · filed 2019-11-06
$15.40M
10-Q · filed 2019-11-06
$27.60M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$3.10M
10-Q · filed 2019-08-08
$13.80M
10-Q · filed 2019-08-08
$25.90M
derived: sum of 3 quarters · filed 2020-02-27
$43.70M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$10.80M
10-Q · filed 2019-05-09
$22.80M
derived: sum of 2 quarters · filed 2020-02-27
$40.60M
derived: sum of 3 quarters · filed 2020-02-27
$64.20M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$12.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$29.80M
derived: sum of 2 quarters · filed 2020-02-27
$53.40M
derived: sum of 3 quarters · filed 2020-02-27
$59.60M
10-K · filed 2020-02-27
2017-09-30$17.80M
10-Q · filed 2018-11-08
$41.40M
derived: sum of 2 quarters · filed 2018-11-08
$47.60M
10-Q · filed 2018-11-08
$51.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01$23.60M
10-Q · filed 2018-08-09
$30.70M
10-Q · filed 2018-08-09
$33.20M
derived: sum of 3 quarters · filed 2019-02-27
$41.80M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01$7.10M
10-Q · filed 2018-05-08
$9.60M
derived: sum of 2 quarters · filed 2019-02-27
$18.20M
derived: sum of 3 quarters · filed 2019-02-27
$24.80M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$11.10M
derived: sum of 2 quarters · filed 2019-02-27
$17.70M
derived: sum of 3 quarters · filed 2019-02-27
$35.80M
10-K · filed 2019-02-27
2016-10-01$8.60M
10-Q · filed 2017-11-09
$15.20M
derived: sum of 2 quarters · filed 2017-11-09
$33.30M
10-Q · filed 2017-11-09
$37.90M
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02$6.60M
10-Q · filed 2017-08-10
$24.80M
10-Q · filed 2017-08-10
$29.30M
derived: sum of 3 quarters · filed 2018-03-01
$31.20M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02$18.20M
10-Q · filed 2017-05-30
$22.70M
derived: sum of 2 quarters · filed 2018-03-01
$24.60M
derived: sum of 3 quarters · filed 2018-03-01
$26.50M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$4.50M
derived: 10-K 6 month − 10-Q/A 3 month · filed 2018-03-01
$6.40M
10-K · filed 2018-03-01
$8.30M
derived: sum of 3 quarters · filed 2018-03-01
$9.00M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26$1.90M
10-Q/A · filed 2017-05-23
$3.80M
derived: sum of 2 quarters · filed 2017-05-23
$4.50M
10-Q/A · filed 2017-05-23
$7.00M
derived: sum of 4 quarters · filed 2017-05-23
2015-06-27$1.90M
10-Q/A · filed 2017-05-22
$2.60M
10-Q/A · filed 2017-05-22
$5.10M
derived: sum of 3 quarters · filed 2017-05-22
$18.50M
10-K · filed 2018-03-01
2015-03-28$700.00K
10-Q/A · filed 2017-05-22
$3.20M
derived: sum of 2 quarters · filed 2017-05-22
$16.70M
10-Q · filed 2015-04-29
$22.80M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27$2.50M
10-Q · filed 2015-02-05
$16.00M
10-Q · filed 2015-02-05
$22.10M
derived: sum of 3 quarters · filed 2017-05-22
$39.10M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27$13.50M
8-K · filed 2014-11-20
$19.60M
derived: sum of 2 quarters · filed 2017-05-22
$36.60M
derived: sum of 3 quarters · filed 2017-05-22
$40.80M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28$6.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
$23.10M
derived: sum of 2 quarters · filed 2017-05-22
$27.30M
derived: sum of 3 quarters · filed 2017-05-22
$28.70M
10-K · filed 2017-05-22
2014-03-29$17.00M
10-Q · filed 2015-04-29
$21.20M
derived: sum of 2 quarters · filed 2015-04-29
$22.60M
10-Q · filed 2015-04-29
2013-12-28$4.20M
10-Q · filed 2015-02-05
$5.60M
10-Q · filed 2015-02-05
2013-09-28$1.40M
8-K · filed 2014-11-20
2013-06-29$1.70M
10-KT · filed 2016-02-25
2012-06-30$100.00K
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38